• Prostate and other male cancers

Camcevi Generic Name & Formulations

General Description

Leuprolide mesylate 42mg; per prefilled syringe; emulsion for SC inj.

Pharmacological Class

GnRH analogue.

How Supplied

Kit—1 (w. supplies)

Generic Availability


Camcevi Indications


Advanced prostate cancer.

Camcevi Dosage and Administration


Give by SC inj on the upper- or mid-abdominal area. Avoid areas with brawny or fibrous tissue or locations that could be rubbed or compressed. 42mg once every 6months.


Not established.

Camcevi Contraindications


Hypersensitivity to GnRH analogues.

Camcevi Boxed Warnings

Not Applicable

Camcevi Warnings/Precautions


May worsen metastatic vertebral lesions and/or urinary tract obstruction; monitor closely during first few weeks. Increased risk of diabetes, MI, sudden cardiac death, stroke. Monitor blood glucose, HbA1c, and for CVD signs/symptoms during therapy. Risk of QT prolongation in those with congenital long QT syndrome, CHF, or frequent electrolyte abnormalities. Correct and monitor electrolyte abnormalities; consider monitoring ECGs. Monitor serum testosterone levels post-inj. Embryo-fetal toxicity. Pregnancy. Nursing mothers: not recommended.

Camcevi Pharmacokinetics

See Literature

Camcevi Interactions


Caution with concomitant drugs known to prolong the QT interval.

Camcevi Adverse Reactions

Adverse Reactions

Hot flush, hypertension, inj site reactions, upper respiratory tract infections, musculoskeletal pain, fatigue, pain in extremity; spinal cord compression, hyperglycemia, convulsions.

Camcevi Clinical Trials

See Literature

Camcevi Note

Not Applicable

Camcevi Patient Counseling

See Literature